Psychedelic Therapeutics & Drug Development Conference
February 26 – 27, 2026 // New Orleans, LA
Join Worldwide Clinical Trials at the Psychedelic Therapeutics & Drug Development Conference.
0
days leftAbout event
This event brings together leading researchers and thought leaders from academia, industry, the nonprofit sector, and government to explore the challenges and opportunities in the research and development of psychedelic therapies for health conditions with significant unmet need. If you’re attending, be sure to stop by and say hello to our team.
Julia Forte, Executive Director of Project Management, will present “Quantifying Study Effort in Psychedelic Clinical Trials” on February 26 at 9:05 AM CT.
Date
Thursday & Friday
February 26-27, 2026
Venue
Omni Royal Orleans
621 St Louis St
New Orleans, LA 70130
Julia Forte
Executive Director, Project Management
Julia Forte holds over 25 years of clinical research industry experience, with a specialty in neuroscience. She has assisted in leading all Phases of clinical trials in large global environments across multiple therapeutic areas, with a focus in major depressive disorder and treatment resistant depression. Over the past few years, Julia has been involved in the oversight and management of trials with psychedelic compounds in treatment resistant depression, MDD, PTSD, and anorexia.
